Timothy Hanna


Radiation therapy is an important part of cancer therapy. Dr. Hanna is currently developing models estimating the population-level benefits of radiation therapy. He is also developing benefit estimates for chemotherapy combined concurrently with radiation. This work involves estimates of overall survival and local control. These models will assist in clinical decision-making, the economic analysis of radiation therapy and inform health policy both in Ontario and internationally.

The population benefits of radiation therapy can be challenged by factors unrelated to patients’ needs. Dr. Hanna’s recent work has focused on identifying these factors for uterine cancer in Ontario, the most common gynecological cancer in the province. His writing has also drawn attention to global issues in cancer control, including access to radiation therapy in developing countries. His vision is to ultimately develop health services interventions that overcome known barriers to optimal outcomes in radiation oncology.


2012 - Assistant Professor, Radiation Oncology, Department of Oncology, Queen's University.
2012 - Member, Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute.
2012 - Radiation Oncologist and Clinician Scientist, Cancer Centre of Southeastern Ontario.
2012 - Clinician-Scientist I, Ontario Institute for Cancer Research (OICR).
2010 - 2012Radiation Oncology Fellow, Collaboration for Cancer Outcomes Research and Evaluation, Liverpool Hospital, Sydney, New South Wales, Australia.
2009M.Sc., Epidemiology, Queen's University.
2007 - 2008Fellow, Health Services and Policy Research, Canadian Institutes of Health Research, Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute.
2004 - 2010Resident, Radiation Oncology, Kingston General Hospital, Cancer Centre of Southeastern Ontario.
2004MD, Faculty of Medicine, University of Toronto.

Research Output

  • Hanna TP, Richardson H, Peng Y, Kong W, Zhang-Salomons J, Mackillop WJ.
    A Population-Based Study of Factors Affecting the Use of Radiotherapy for Endometrial Cancer.
    • Clin Onc (R Coll Radiol). 24(8) 2012, e113-124.
  • Ginsburg O*, Hanna TP* (*Equal Contribution), Vandenberg T, Joy AA, Clemons M, Game M, Maccormick R, Elit LM, Rosen B, Rahim Y, Geddie W, Sutcliffe SB, Gospodarowicz M.
    The Global Cancer Epidemic: Opportunities for Canada in Low-and Middle-Income Countries.
    • Canadian Medical Association Journal. 184(15) 2012, 1699-1704.
  • Mahmud A, Brydon B, Tonita J, Hanna TP, Schmidt M, Tai P.
    A Population-Based study of Cervix Cancer: Incidence, Management and Outcome in the Canadian province of Saskatchewan.
    • Clin Onc (R Coll Radiol). 23(10) 2011, 691-695.
  • Hanna TP, Kangolle ACT.
    Cancer Control in Developing Countries: Using Health Data and Health Services Research to Measure and Improve Access, Quality and Efficiency.
    • BMC Journal of International Health and Human Rights. 10(24) 2010. http://www.biomedcentral.com/1472-698X/10/24.
  • Hanna T.
    Radiation Oncology in the Developing World.
    • In: Principles and Practice of Radiation Oncology 5th (& 6th Ed). Perez CA, Brady LW, Halperin EC, Schmidt-Ullrich RK, eds. Lippincott Williams and Wilkins. New York, 2008.